Advertisement
UK markets closed

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • HANG SENG

    16,248.97
    -351.49 (-2.12%)
     

  • CRUDE OIL

    85.41
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,410.30
    +27.30 (+1.15%)
     

  • DOW

    37,884.81
    +149.70 (+0.40%)
     

  • Bitcoin GBP

    50,541.43
    -177.64 (-0.35%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • NASDAQ Composite

    15,909.51
    +24.49 (+0.15%)
     

  • UK FTSE All Share

    4,260.41
    -78.49 (-1.81%)
     
Money:

How to avoid tax creep in retirement

The state pension went up 8.5% in April, but frozen thresholds mean pensioners will be paying more tax

Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3%

Zacks Equity Research
·2-min read

Corbus Pharmaceuticals Holdings, Inc. CRBP was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.25 to $1.52 in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Corbus Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Corbus Pharmaceuticals Holdings, Inc. Price

Corbus Pharmaceuticals Holdings, Inc. Price
Corbus Pharmaceuticals Holdings, Inc. Price

Corbus Pharmaceuticals Holdings, Inc. price | Corbus Pharmaceuticals Holdings, Inc. Quote

ADVERTISEMENT

A better-ranked stock in the Medical - Drugs industry is Organogenesis Holdings Inc. ORGO, holding a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Corbus Pharmaceuticals Holdings, Inc. (CRBP) : Free Stock Analysis Report
 
ORGANOGENESIS (ORGO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research